- Investing Ideas
- Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Daiichi Sankyo Company
Market Cap: JP¥4.8t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,691.50
7D
-2.4%
1Y
-19.4%
Sumitomo Pharma
Market Cap: JP¥628.0b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,341.50
7D
-13.6%
1Y
30.0%
GNI Group
Market Cap: JP¥169.1b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,570.00
7D
-10.9%
1Y
-16.4%
PeptiDream
Market Cap: JP¥130.0b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,012.00
7D
-2.7%
1Y
-38.0%
Nxera Pharma
Market Cap: JP¥83.0b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥896.00
7D
-7.8%
1Y
3.6%
SanBio
Market Cap: JP¥78.8b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥1,010.00
7D
-4.3%
1Y
-53.4%
Fuji Pharma
Market Cap: JP¥48.9b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,872.00
7D
-6.1%
1Y
39.7%
Heartseed
Market Cap: JP¥36.8b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,609.00
7D
-6.2%
1Y
-55.3%
Healios K.K
Market Cap: JP¥35.6b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥264.00
7D
4.8%
1Y
-50.5%
StemRIM
Market Cap: JP¥18.8b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥300.00
7D
-2.3%
1Y
0.7%
Kidswell Bio
Market Cap: JP¥7.5b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥151.00
7D
-1.9%
1Y
-42.6%
Noile-Immune Biotech
Market Cap: JP¥5.9b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥137.00
7D
7.0%
1Y
-20.8%
TMS
Market Cap: JP¥4.7b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥104.00
7D
-1.9%
1Y
-39.9%